Citrelock ACL Tendon Fixation Device. Credit: Acuitive Technologies/GlobeNewswire.

Acuitive Technologies has introduced its new Citrelock ACL Tendon Fixation Device for sports medicine.

Rutgers-New Jersey Medical School orthopaedics professor Robin Gehrmann completed the implantation of the first ACL device, saying: “By leveraging Citregen’s unique material properties, the Citrelock Tendon Fixation Device introduces design features to ease insertion and secure fixation without damaging the tendon during placement.”

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The new device offers surgeons a differentiated design through a tendon-friendly spiral thread, which features a next-generation resorbable technology called Citregen.

Citregen has unique molecular and mechanical properties for orthopaedic surgical applications.

The device provides biomimetic material composition to match the native bone inorganic content, as well as a compressive strength that is similar to cortical bone and a modulus-like trabecular bone.

See Also:

It also offers elastomeric properties for enhanced pull-out strength and a controlled resorption rate to address chronic inflammation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Acuitive product development vice-president Rui Ferreira said: “The Citrelock ACL Tendon Fixation Device helps fill that clinical need with its innovative material technology and unique design.

“Citrelock ACL System is an exciting addition to Acuitive’s portfolio and is the first in a series of new products we will be launching with a focus on the Sports Medicine market.”

Acuitive is involved in the development of advanced biomaterials and orthopaedic devices to support the natural healing process of musculoskeletal tissues.